Hansi Weissensteiner - Epidemiology

Author Information

Hansi Weissensteiner is associated with the Institute of Genetic Epidemiology at the Medical University of Innsbruck, located in Innsbruck, Austria. Hansi Weissensteiner's research contributions span various facets of genetic epidemiology, with a specific focus on mitochondrial DNA and its implications in diseases and metabolic conditions.

Research Contributions

Hansi Weissensteiner's work has significantly contributed to the understanding of mitochondrial DNA and its role in various diseases. In 2021 alone, Weissensteiner co-authored numerous impactful papers. These include studies on the concentrations of Apolipoprotein A-IV in chronic kidney disease, advancements in variant calling pipelines for mtDNA, the first mitochondrial genome-wide association study with metabolomics, and tools for analyzing SARS-CoV-2 variation. Additionally, Weissensteiner has explored the mitochondrial phylogenetic landscape of Cambodia, associations between mtDNA copy number and metabolic syndrome, and contamination detection in sequencing studies. These diverse contributions underscore Weissensteiner's influence on genetic epidemiology and mitochondrial research.

Aliases

Hansi Weissensteiner is also known by the aliases H. Weissensteiner, Hansi Weissensteiner, and Hansi Weißensteiner. These variations are used interchangeably in academic and research publications.

Publication and Citation Metrics

Metric	Value
Citation Count	2110
H-index	18
Paper Count	54

Publications:

Apolipoprotein A‐IV concentrations and clinical outcomes in a large chronic kidney disease cohort: Results from the GCKD study

DOI: 10.1111/joim.13437

Year: 2021

From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel

DOI: 10.3390/ijms222112031

Year: 2021

First mitochondrial genome wide association study with metabolomics.

DOI: 10.1093/hmg/ddab312

Year: 2021

Analyzing Low-Level mtDNA Heteroplasmy—Pitfalls and Challenges from Bench to Benchmarking

DOI: 10.3390/ijms22020935

Year: 2021

CovidPhy: A tool for phylogeographic analysis of SARS-CoV-2 variation

DOI: 10.1016/j.envres.2021.111909

Year: 2021

An in-depth analysis of the mitochondrial phylogenetic landscape of Cambodia

DOI: 10.1038/s41598-021-90145-2

Year: 2021

Association of mitochondrial DNA copy number with metabolic syndrome and type 2 diabetes in 14 176 individuals

DOI: 10.1111/joim.13242

Year: 2021

Contamination detection in sequencing studies using the mitochondrial phylogeny.

DOI: 10.1101/gr.256545.119

Year: 2021

Implications of Standardized Uptake Values of Oral Squamous Cell Carcinoma in PET-CT on Prognosis, Tumor Characteristics and Mitochondrial DNA Heteroplasmy

DOI: 10.3390/cancers13092273

Year: 2021

OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation

DOI: 10.1038/s41467-020-15237-5

Year: 2020

What Are Health Departments?

What are Ethnic and Racial Disparities?

Where to Publish?

What are the Epidemiological Trends of RHD?

What is the Role of Evidence-Based Medicine (EBM) in Clinical Decisions?

What Factors Influence Resource Allocation?

Why is the Amplification Effect Important in Epidemiology?

How do Epidemiologists Study Infections?

What are Antibiotics and Antivirals?

When Are Direct Observations Most Useful?

Partnered Content Networks

Relevant Topics